Science News -- Science Advisory Board Formed By Growth Stock Company - Former SmithKline Beecham Clinical Laboratories Senior VP To Head Growth Stock Companys Science Advisory Board

Science News -- New news on science growth stock company -- CalbaTech, Inc (Stock Symbol = CLBE) forms science advisory board -- Former SmithKline Beecham Clinical Laboratories Senior VP to lead new science advisory board.

IRVINE, CA (PRWEB) July 31, 2003 -- Former SmithKline Beecham Clinical Laboratories Senior Vice President, David OBryan, Ph.D., has been appointed to the newly formed Scientific Advisory Board of growth company CalbaTech, Inc. (OTC BB: CLBE).

To assist its direction and growth, CalbaTech, Inc. has created a Scientific Advisory Board. Dr. OBryan, a clinical testing expert with significant experience in developing new technologies, has been appointed as the Boards first member.

CalbaTech (http://www.calbatech.com) is a life sciences growth company expanding by acquiring, incubating and developing early stage companies in selected sectors including Bio-Informatics, Bio-Security and Platform Reagents.

The Company offers the potential for higher returns with lower risks by focusing on products or technologies that will generate sales or licensing revenues in less than two years, and will require less than one million dollars to bring a product to market.

We are pleased that a man of Dr. OBryans accomplishments and experience will be assisting CalbaTech in making the proper scientific decisions on which technologies should be focused upon to maximize revenues and shareholder value," said Edward Deese, President of CalbaTech.

Dr. OBryan has more than 28 years experience in the clinical testing industry, including significant experience in developing new technologies. On behalf of SmithKline Beecham Clinical Laboratories he negotiated license agreements involving patented gene sequences used to diagnose diseases and secured the first license for nucleic acid testing. More information on Dr. OBryan can be found at http://www.calbatech.com/advisory.htm.

CalbaTech is focused on life science based companies that are developing next generation products and technologies, both in the United States as well as in the United Kingdom. The market focus of CalbaTech on life sciences primarily reflects the interests and experiences of the founders, its collaborators and its partners.

For more information visit http://www.CalbaTech.com/life-sciences.htm.

Note: Certain statements in this news release may contain "forward looking" information within the meaning of rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Act of 1934 and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, may include forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will be accurate and actual results and future events could differ materially from those anticipated in such statements.